3P4-83442-42752 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-20
Dose 1 — Pfizer-BioNTech
2021-12-11
Dose 2 — Pfizer-BioNTech
2021-12-22
Registered in v-safe
2021-12-22
Health check-in — day 7, dose 2, dependent
Feeling: Good · None

Adult check-in
2021-12-26
Health check-in — day 14, dose 2, dependent
Feeling: Good

Adult check-in
2022-01-01
Health check-in — day 21, dose 2, dependent
Feeling: Good

Adult check-in
2022-01-08
Survey response — day 28, dose 2, dependent
MedDRA: Hyperaesthesia, Rash, Rash macular, Self-medication — Feeling: Good

Free text: Splotchy red rashes on trunk and extremities, and increased skin sensitivity 7 days out of the past 7, more severe than other vaccinated sibling, improves with OTC antihistamine but returns as dosing wears off

MedDRA releases: 2024-11 · check-in free text available
2022-01-15
Health check-in — day 35, dose 2, dependent
Feeling: Good

Adult check-in
2022-01-22
Health check-in — day 42, dose 2, dependent
Feeling: Good

Adult check-in
2022-03-12
Survey response — 3 months, dose 2, dependent
MedDRA: Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Latex allergy

MedDRA releases: 2024-11 · check-in free text available
2022-03-12
Report sent to call center — 3 months, dose 2, dependent
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-03-17
Call 1 — Left Voicemail
2022-06-11
Survey response — 6 months, dose 2, dependent
MedDRA: Condition aggravated, Pre-existing disease, Rubber sensitivity, Urticaria — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Increased incidence of dermatographia and urticaria. Link to new latex allergy or another allergy or condition is being considered by allergist over the next few months. Otherwise healthy and definitely faring well Covid-wise, no illnesses

MedDRA releases: 2024-11 · check-in free text available
2022-06-11
Report sent to call center — 6 months, dose 2, dependent
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-06-14
Call 2 — Left Voicemail
2022-06-14
Call 1 — Left Voicemail
2022-07-27
Dose 3 — Pfizer-BioNTech
2022-07-28
Health check-in — days 1–6 daily, dose 3, dependent
Feeling: Good · Site: Pain, Itching · Fatigue or tiredness

Adult check-in
2022-07-30
Survey response — days 1–6 daily, dose 3, dependent
MedDRA: Axillary pain — Feeling: Good · Site: Pain

Free text: Under arm soreness/pain, lymph nodes NOT enlarged

MedDRA releases: 2024-11 · check-in free text available
2022-08-02
Health check-in — days 1–6 daily, dose 3, dependent
Feeling: Good · None

Adult check-in
2022-08-05
Survey response — day 7, dose 3, dependent
MedDRA: Mechanical urticaria, Urticaria — Feeling: Good

Free text: Urticaria/ dermatographia

MedDRA releases: 2024-11 · check-in free text available
2022-08-12
Health check-in — day 14, dose 3, dependent
Feeling: Good

Adult check-in
2022-08-20
Health check-in — day 21, dose 3, dependent
Feeling: Good

Adult check-in
2022-09-09
Health check-in — day 42, dose 3, dependent
Feeling: Good

Adult check-in
2023-01-27
Health check-in — 6 months, dose 3, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-20	Pfizer-BioNTech	No
2	2021-12-11	Pfizer-BioNTech	No
3	2022-07-27	Pfizer-BioNTech	No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 10 — day 28, dose 2, dependent

2022-01-08

Symptoms: Splotchy red rashes on trunk and extremities, and increased skin sensitivity 7 days out of the past 7, more severe than other vaccinated sibling, improves with OTC antihistamine but returns as dosing wears off

Release 11 — 3 months, dose 2, dependent

2022-03-12

Symptoms: Latex allergy

Release 12 — 6 months, dose 2, dependent

2022-06-11

Symptoms: Increased incidence of dermatographia and urticaria. Link to new latex allergy or another allergy or condition is being considered by allergist over the next few months. Otherwise healthy and definitely faring well Covid-wise, no illnesses

Release 12 — days 1–6 daily, dose 3, dependent

2022-07-30

Systemic reaction (other): Under arm soreness/pain, lymph nodes NOT enlarged

Release 12 — day 7, dose 3, dependent

2022-08-05

Systemic reaction (other): Urticaria/ dermatographia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Condition aggravated	·	·	✓
SD	Hyperaesthesia	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Rash	·	·	✓
SD	Rash macular	·	·	✓
SD	Rubber sensitivity	·	·	✓
SD	Self-medication	·	·	✓
SD	Urticaria	·	·	✓
SRO	Axillary pain	·	·	✓
SRO	Mechanical urticaria	·	·	✓
SRO	Urticaria	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release